Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
SnapShot: the microbiota-gut-brain axis
Additionally, parenteral GLP-1 treatments have strong clinical validation, which increases physician confidence and patient adherence, further driving market dominance
human evidence is still emerging.) Musculoskeletal injury or post-surgical recovery Chronic tendonitis, ligament sprains, or joint pain Athletes or active individuals with overuse injuries Patients with GI inflammation or ulcerative symptoms Individuals seeking regenerative or anti-inflammatory support Generally well-tolerated in available data, but may include: Mild redness or irritation at injection site Transient headache, nausea, or dizziness (rare) Potential for allergic reaction (rare) Not FDA-approved
In January 2026, Century reinforced that pivot by announcing an oversubscribed $135 million private placement financing aimed at advancing CNTY-813 and supporting an IND submission targeted for 2026
US$ 27.33
US$ 26.54
US$ 24.39
US$ 26.60
US$ 22.20
